DE69431430D1 - Faktor XIII zur Behandlung von Hautwunden - Google Patents

Faktor XIII zur Behandlung von Hautwunden

Info

Publication number
DE69431430D1
DE69431430D1 DE69431430T DE69431430T DE69431430D1 DE 69431430 D1 DE69431430 D1 DE 69431430D1 DE 69431430 T DE69431430 T DE 69431430T DE 69431430 T DE69431430 T DE 69431430T DE 69431430 D1 DE69431430 D1 DE 69431430D1
Authority
DE
Germany
Prior art keywords
factor xiii
treatment
skin wounds
skin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69431430T
Other languages
English (en)
Other versions
DE69431430T2 (de
Inventor
Naoko Kato
Takashi Ogawa
Shuji Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE69431430D1 publication Critical patent/DE69431430D1/de
Application granted granted Critical
Publication of DE69431430T2 publication Critical patent/DE69431430T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69431430T 1993-03-30 1994-03-02 Faktor XIII zur Behandlung von Hautwunden Expired - Lifetime DE69431430T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7139593 1993-03-30
PCT/IB1994/000040 WO1994022470A1 (en) 1993-03-30 1994-03-02 Factor xiii for treatment of skin wounds

Publications (2)

Publication Number Publication Date
DE69431430D1 true DE69431430D1 (de) 2002-10-31
DE69431430T2 DE69431430T2 (de) 2003-05-22

Family

ID=13459291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69431430T Expired - Lifetime DE69431430T2 (de) 1993-03-30 1994-03-02 Faktor XIII zur Behandlung von Hautwunden

Country Status (7)

Country Link
EP (1) EP0691850B1 (de)
KR (1) KR100302935B1 (de)
AT (1) ATE224727T1 (de)
AU (1) AU674061B2 (de)
DE (1) DE69431430T2 (de)
ES (1) ES2182840T3 (de)
WO (1) WO1994022470A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4784693A (en) 1992-07-24 1994-02-14 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
IL125983A0 (en) * 1998-08-30 1999-04-11 Yeda Res & Dev Pharmaceutical composition comprising factor xiiia
ES2303561T3 (es) 2001-10-09 2008-08-16 Zymogenetics, Inc. Metodo para inhibir la formacion de seromas utilizando el factor xiii.
US20050142208A1 (en) 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
EP1566183A1 (de) * 2004-02-20 2005-08-24 ZLB Behring GmbH Verwendung vom Faktor XIII zur Stimulierung der Durchblutung von ischämischem Gewebe
JP6244079B2 (ja) 2008-04-21 2017-12-06 ノボ ノルディスク ヘルス ケア アーゲー 乾燥トランスグルタミナーゼ組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
ATE121776T1 (de) * 1986-09-19 1995-05-15 Zymogenetics Inc Expression des biologisch aktiven faktors xiii.
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
EP0691850A1 (de) 1996-01-17
WO1994022470A1 (en) 1994-10-13
KR960701657A (ko) 1996-03-28
AU674061B2 (en) 1996-12-05
ATE224727T1 (de) 2002-10-15
DE69431430T2 (de) 2003-05-22
AU6155794A (en) 1994-10-24
ES2182840T3 (es) 2003-03-16
EP0691850B1 (de) 2002-09-25
KR100302935B1 (ko) 2001-11-30

Similar Documents

Publication Publication Date Title
Nalbandian et al. Pluronic F‐127 gel preparation as an artificial skin in the treatment of third‐degree burns in pigs
US3777016A (en) Composition and method for the treat-ment of damaged skin
DE69334145D1 (de) Terfenadin-Carboxylat und die Behandlung von Hautreizung
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
JP3550685B2 (ja) 創傷治療剤
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
ATE131064T1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
US5024838A (en) Compositions for the treatment of skin injuries
KR930019224A (ko) 유산 위험 치료제
ATE171071T1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
ATE281157T1 (de) Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen
CA2159609A1 (en) Factor xiii for treatment of skin wounds
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
Prescott Doxil offers hope to KS sufferers
EP0880967A3 (de) Nephroprotektive Arzneimittel
RU2093093C1 (ru) Способ лечения глубоких отморожений пальцев кисти
RU2003344C1 (ru) Способ лечени ожоговой болезни
US20190209639A1 (en) Ointment for burn
Krizek Wound and reconstructive problems in advanced disease
RU2191004C2 (ru) Способ консервативного лечения отморожения конечностей

Legal Events

Date Code Title Description
8364 No opposition during term of opposition